17.79BMarket Cap
21.75P/E TTM
Genmab A/S's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Genmab A/S is 9.22, ranking 25 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 21.75, which is 3.15% below the recent high of 22.43 and 95.36% above the recent low of 1.01.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.